Article
The impact of SAMHD1 expression and mutation status in mantle cell lymphoma: An analysis of the MCL Younger and Elderly trial.
International journal of cancer - 1 Jan 2021
Roider Tobias, Wang Xi, Hüttl Katrin, Müller-Tidow Carsten, Klapper Wolfram, Rosenwald Andreas, Stewart James Peter, de Castro David Gonzalez, Dreger Peter, Hermine Olivier, Kluin-Nelemans Hanneke C, Grabe Niels, Dreyling Martin, Pott Christiane, Ott German, Hoster Eva, Dietrich Sascha
Abstract excerpt
The sterile alpha motif and histidine-aspartic domain-containing protein 1 (SAMHD1) has been demonstrated to predict the response to high-dose cytarabine consolidation treatment in acute myeloid leukemia patients. Here, we evaluated SAMHD1 as potential biomarker for the response to high-dose cytarabine in mantle cell lymphoma (MCL) patients. We quantified SAMHD1 protein expression and determined the mutation...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
